Clinical Trials Browser

Refractory Differentiated Thyroid Gland Carcinoma × cabozantinib × 90 days × Clear all

NCT06475989 2026-03-02

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Phase 3 Recruiting

Refractory Differentiated Thyroid Gland Carcinoma